Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-02

Clinical Trial Update: Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma [NA]

View source ↗

Summary

A completed clinical trial evaluating the pharmacodynamic effects of ribavirin in patients with tonsil and/or base of tongue squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ribavirin (ribavirin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: HEAD & NECK Cancer | NA | Status: COMPLETED | Results posted: 2023-10-02